| Insider | Kieser Brian Joseph |
|---|---|
| Title | Director |
| Transaction Date | Nov 10, 2026 |
| Exercise Date | Apr 17, 2026 |
| Expiration Date | Apr 17, 2031 |
| Transaction Code | D Sale to Issuer |
| Acquired/Disposed | Acquired |
| Security | Existing Warrant (before amendment) |
| Derivative | Yes |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Sequence LifeScience, Inc. |
| Filing Date | Nov 14, 2026 |
| Shares Purchased | 229,167 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Derivative | Derivative |
| Accession Number | 0001493152-26-051920 |
| Document | View SEC Filing |